Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
NovoCure (NVCR) Gets a Buy Rating from Mizuho Securities
08:10am, Friday, 01'st May 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on NovoCure (NVCR) today and set a price target of $82.00. The company's shares closed last
NovoCure (NVCR) Gets a Buy Rating from Mizuho Securities
08:10am, Friday, 01'st May 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on NovoCure (NVCR – Research Report) today and set a price
Edited Transcript of NVCR earnings conference call or presentation 30-Apr-20 12:00pm GMT
10:17pm, Thursday, 30'th Apr 2020
Q1 2020 Novocure Ltd Earnings Call
Highly Rated Cancer Play Tumbles As Key Studies Delayed Amid Outbreak
08:05pm, Thursday, 30'th Apr 2020
Novocure stock sagged Thursday after the cancer treatment specialist delayed the results of several key studies and reported first-quarter measures that lagged some estimates.
NovoCure Limited (NVCR) CEO Asaf Danziger on Q1 2020 Results - Earnings Call Transcript
06:33pm, Thursday, 30'th Apr 2020
NovoCure Limited (NASDAQ:NVCR) Q1 2020 Earnings Conference Call April 30, 2020 08:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Financ
Russell 2000 Retreats
04:12pm, Thursday, 30'th Apr 2020
The Russell 2000 Index is pulling back today after hitting a major resistance level yesterday.
NovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates
11:30am, Thursday, 30'th Apr 2020
NovoCure (NVCR) delivered earnings and revenue surprises of -20.00% and -2.19%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates
11:30am, Thursday, 30'th Apr 2020
NovoCure (NVCR) delivered earnings and revenue surprises of -20.00% and -2.19%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
BRIEF-Novocure Q1 Net Profit $4Mln Versus -$12.2 Mln Loss Year Ago
10:34am, Thursday, 30'th Apr 2020
Novocure Ltd:
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
10:00am, Thursday, 30'th Apr 2020
Novocure reported financial results for the first quarter of 2020 and provided a company update.
NovoCure Q1 2020 Earnings Preview
09:30pm, Wednesday, 29'th Apr 2020
NovoCure (NASDAQ:NVCR) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is $0.03 (+123.1% Y/Y) and the consensus Revenue Estimate is
BRIEF-Novocure Announces Presentation Of EF-19 Post-Approval Registry Trial Data
11:54am, Monday, 27'th Apr 2020
Novocure Ltd:
Novocure announced that EF-19 post-approval registry trial data will be presented at the AACR 2020 Virtual Annual Meeting I.
Analysts Anticipate Novocure Ltd (NASDAQ:NVCR) to Announce $0.06 Earnings Per Share
06:18am, Sunday, 26'th Apr 2020
Equities analysts expect that Novocure Ltd (NASDAQ:NVCR) will post earnings per share of $0.06 for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Novocur
